In conclusion, we confirmed serum FGF-19 and FGF-21 as useful new markers of obesity-related metabolic alternations and we robustly propose Rb as a novel indicator of excessive body adiposity and its early consequences. This evidence concerns the gene FGF19 and obesity due to melanocortin 4 receptor deficiency.